NES
VRTX icon

New England Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

New England Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$107K Hold
900
– – 0.04% 411
2014
Q3 		$101K Hold
900
– – 0.04% 425
2014
Q2 		$85K Sell
900
-13
-1% -$912 0.03% 477
2014
Q1 		$65K Buy
913
+4
+0.4% +$317 0.03% 486
2013
Q4 		$68K Sell
909
-38
-4% -$2.65K 0.03% 475
2013
Q3 		$72K Hold
947
– – 0.04% 424
2013
Q2 		$76K Buy
+947
New +$69.7K 0.05% 339

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

New England Securities's VRTX Position: Q4 2014 in Review

New England Securities held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2014 at 900 shares worth $107K. The position accounts for 0.04% of the portfolio, ranked #411.

New England Securities first reported a position in VRTX in Q2 2013 and has held it in 7 quarters since. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • New England Securities held 900 shares of Vertex Pharmaceuticals worth $107K as of Q4 2014.
  • New England Securities left its Vertex Pharmaceuticals share count unchanged in Q4 2014.
  • Vertex Pharmaceuticals made up 0.04% of New England Securities's portfolio in Q4 2014, its #411 holding.
  • New England Securities first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.